Migalastat Hydrochloride
Who holds supplier records for Migalastat Hydrochloride? 6 organisations hold a current record for Migalastat Hydrochloride: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (3), Switzerland (1) and Netherlands (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Migalastat Hydrochloride: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/migalastat-hydrochloride
Reading the evidence
- 6 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
3 of the 5 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 3 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (6)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Migalastat Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- METROCHEM API PRIVATE LTDIndiaActive DMF 37632, 43300 · latest filing Dec 2025
- APITORIA PHARMA PRIVATE LTDIndia Company GMP cert on recordActive DMF 36827 · latest filing Feb 2022
- DIPHARMA SASwitzerland Company GMP cert on recordActive DMF 42278 · latest filing Jul 2025
- LUPIN MANUFACTURING SOLUTIONS LTDActive DMF 36729 · latest filing Mar 2022
- MSN Laboratories Private LimitedIndia Company GMP cert on recordActive DMF 38135 · latest filing Mar 2023
- TAPI NL BVNetherlandsActive DMF 36618 · latest filing Feb 2022
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Migalastat Hydrochloride is an orally administered pharmacological chaperone designed to treat Fabry disease by stabilizing specific mutant forms of the alpha-Galactosidase A enzyme. It aids in trafficking the dysfunctional enzyme to lysosomes, thus potentially restoring its normal function.
Chemical identity
- IUPAC name
- (2R,3S,4R,5S)-2-(hydroxymethyl)piperidine-3,4,5-triol;hydrochloride
- Canonical SMILES
- C1[C@@H]([C@H]([C@H]([C@H](N1)CO)O)O)O.Cl
- InChIKey
- ZJIHMALTJRDNQI-OLALXQGDSA-N
- Synonyms
- Galafold API, (+)-migalastat hydrochloride, 1-deoxygalactonojirimycin hydrochloride, at-1001 (migalastat hydrochloride), galafold, migalastat hcl
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Migalastat Hydrochloride?
6 organisations hold an active US FDA Type II Drug Master File or a CEP for Migalastat Hydrochloride: METROCHEM API PRIVATE LTD (India), APITORIA PHARMA PRIVATE LTD (India), DIPHARMA SA (Switzerland), LUPIN MANUFACTURING SOLUTIONS LTD, MSN Laboratories Private Limited (India) and TAPI NL BV (Netherlands). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Migalastat Hydrochloride Drug Master Files are active?
METROCHEM API PRIVATE LTD (DMF 37632, 43300), APITORIA PHARMA PRIVATE LTD (DMF 36827), DIPHARMA SA (DMF 42278), LUPIN MANUFACTURING SOLUTIONS LTD (DMF 36729), MSN Laboratories Private Limited (DMF 38135) and TAPI NL BV (DMF 36618). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
How do I qualify a Migalastat Hydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Migalastat Hydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.